The polycystic ovary syndrome evolutionary paradox: A genome-wide association studies-based, in silico, evolutionary explanation

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 11, 2014, Pages E2412-E2420

  Casarini, Livio ^a   Brigante, Giulia ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BAYES THEOREM; COMPUTER MODEL; DATA BASE; ETHNICITY; EVOLUTION; FEMALE; FOUNDER EFFECT; GENE CLUSTER; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC DISTANCE; GENETIC DRIFT; GENETIC SIMILARITY; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE MAP; HUMAN; HUMAN GENOME PROJECT; MIGRATION; NATURAL SELECTION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENETIC PREDISPOSITION; GENETICS; MALE; PHENOTYPE;

ALLELES; BAYES THEOREM; BIOLOGICAL EVOLUTION; FEMALE; GENE FREQUENCY; GENETIC DRIFT; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84909998765     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2703     Document Type: Article

References (70)

1. Domecq JP, Prutsky G, Mullan RJ, et al. Lifestyle modification programs in polycystic ovary syndrome: Systematic review and metaanalysis. J Clin Endocrinol Metab. 2013; 98: 4655-4663.
2. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2013; 98: 4565-4592.
3. Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ. The contribution of diet, physical activity and sedentary behaviour to body mass index inwomenwith and without polycystic ovary syndrome. Hum Reprod. 2013; 28: 2276-2283.
4. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19: 41-47.
5. Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol. 2008; 198: 670.e1-7.
6. Mojiminiyi OA, Safar FH, Al Rumaih H, Diejomaoh M. Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age. Scand J Clin Lab Invest. 2010; 70: 554-560.
7. WijeyaratneCN, Seneviratne Rde A, Dahanayake S, et al. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): Results of a large database from a specialist Endocrine Clinic. Hum Reprod. 2011; 26: 202-213.
8. Dunaif A, Fauser BC. Renaming PCOS-a two-state solution. J Clin Endocrinol Metab. 2013; 98: 4325-4328.
9. Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: A large-scale case-control study. Arch Gynecol Obstet. 2013; 287: 525-531.
10. Zhao Y, Qiao J. Ethnic differences in the phenotypic expression of polycystic ovary syndrome. Steroids. 2013; 78: 755-760.
11. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab. 1999; 84: 4006-4011.
12. Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar- Morreale HF.Aprospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000; 85: 2434-2438.
13. Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol. 2008; 168: 321-328.
14. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89: 2745-2749.
15. Wang S, Alvero R. Racial and ethnic differences in physiology and clinical symptoms of polycystic ovary syndrome. Semin Reprod Med. 2013; 31: 365-369.
16. Corbett S, Morin-Papunen L. The polycystic ovary syndrome and recent human evolution. Mol Cell Endocrinol. 2013; 373: 39-50.
17. Azziz R, Dumesic DA, Goodarzi MO. Polycystic ovary syndrome: An ancient disorder? Fertil Steril. 2011; 95: 1544-1548.
18. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab. 1994; 79: 1052-1058.
19. Louwers YV, Stolk L, UitterlindenAG, Laven JS. Cross-ethnic metaanalysis of genetic variants for polycystic ovary syndrome. J Clin Endocrinol Metab. 2013; 98: E2006-12.
20. Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011; 43: 55-59.
21. Shi Y, ZhaoH, Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012; 44: 1020-1025.
22. Simoni M, Tempfer CB, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update. 2008; 14: 459-484.
23. Unsal T, Konac E, Yesilkaya E, et al. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. J Assist Reprod Genet. 2009; 26: 205-216.
24. GuBH, Park JM, Baek KH. Genetic variations of follicle stimulating hormone receptor are associated with polycystic ovary syndrome. Int J Mol Med. 2010; 26: 107-112.
25. Eriksen MB, Brusgaard K, Andersen M, et al. Association of polycystic ovary syndrome susceptibility single nucleotide polymorphism rs2479106 and PCOS in Caucasian patients with PCOS or hirsutism as referral diagnosis. Eur J Obstet Gynecol Reprod Biol. 2012; 163: 39-42.
26. Goodarzi MO, Jones MR, Li X, et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet. 2012; 49: 90-95.
27. Li T, Zhao H, Zhao X, et al. Identification of YAP1 as a novel susceptibility gene for polycystic ovary syndrome. J Med Genet. 2012; 49: 254-257.
28. Welt CK, Styrkarsdottir U, Ehrmann DA, et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012; 97: E1342-1347.
29. Mutharasan P, Galdones E, Peñalver Bernabé B, et al. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab. 2013; 98: E185-190.
30. Coop G, Pickrell JK, Novembre J, et al. The role of geography in human adaptation. PLoS Genet. 2009; 5: e1000500.
31. Pickrell JK, Coop G, Novembre J, et al. Signals of recent positive selection in a worldwide sample of human populations. Genome Research. 2009; 19: 826-837.
32. Pritchard JK, Pickrell JK, Coop G. The genetics of human adaptation: Hardsweeps, soft sweeps, and polygenic adaptation. Curr Biol. 2010; 20: R208-215.
33. CannHM, deTomaC, Cazes L, et al.Ahuman genome diversity cell line panel. Science. 2002; 296: 261-262.
34. Cavalli-Sforza LL. The human genome diversity project: Past, present and future. Nat Rev Genet. 2005; 6: 333-340.
35. Cui L, Zhao H, Zhang B, et al. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod. 2013; 28: 538-544.
36. Ramachandran S, Deshpande O, Roseman CC, Rosenberg NA, Feldman MW, Cavalli-Sforza LL. Support from the relationship of genetic and geographic distance in human populations for a serial founder effect originating in Africa. Proc Natl Acad SciUSA. 2005; 102: 15942-15947.
37. Li JZ, Absher DM, Tang H, et al. Worldwide human relationships inferred from genome-wide patterns of variation. Science. 2008; 319: 1100-1104.
38. Abecasis GR, Altshuler D, Auton A, et al. A map of human genome variation from population-scale sequencing. Nature. 2010; 467: 1061-1073.
39. The International HapMap Consortium. The International Hap- Map Project. Nature. 2003; 426: 789-796.
40. Pritchard JK, StephensM, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000; 155: 945-959.
41. Evanno G, Regnaut S, Goudet J. Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study. Mol Ecol. 2005; 14: 2611-2620.
42. Sharov AA, Dudekula DB, Ko MS. A web-based tool for principal component and significance analysis of microarray data. Bioinformatics. 2005; 21: 2548-2549.
43. Wright S. Isolation by distance. Genetics. 1943; 28: 114-138.
44. Henn BM, Cavalli-Sforza LL, Feldman MW. The great human expansion. Proc Natl Acad Sci U S A. 2012; 109: 17758-17764.
45. Rosenberg NA, Pritchard JK, Weber JL, et al. Genetic structure of human populations. Science. 2002; 298: 2381-2385.
46. Valkenburg O, Uitterlinden AG, Piersma D, et al. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod. 2009; 24: 2014-2022.
47. Hwang JY, Lee EJ, Jin Go M, et al. Genome-wide association study identifies GYS2 as a novel genetic factor for polycystic ovary syndrome through obesity-related condition. J Hum Genet. 2012; 57: 660-664.
48. Zadeh-Vakili A, Ramezani Tehrani F, Daneshpour MS, Zarkesh M, Saadat N, Azizi F. Genetic polymorphism of vitaminDreceptor gene affects the phenotype of PCOS. Gene. 2013; 515: 193-196.
49. Dowling AR, Nedorezov LB, Qiu X, Marino JS, Hill JW. Genetic factors modulate the impact of pubertal androgen excess on insulin sensitivity and fertility. PLoS One. 2013; 8: e79849.
50. Fu L, Zhang Z, Zhang A, et al. Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women. J Assist Reprod Genet. 2013; 30: 717-721.
51. Pau C, Saxena R, Welt CK. Evaluating reported candidate gene associations with polycystic ovary syndrome. Fertil Steril. 2013; 99: 1774-1778.
52. Skrgati L, Baldani DP, Gersak K, Cerne JZ, Ferk P, Cori M. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women. Coll Antropol. 2013; 37: 141-146.
53. Xu P, Shen SM, Zhang XL, et al. Haplotype analysis of single nucleotide polymorphisms in anti-Müllerian hormone gene in Chinese PCOS women. Arch Gynecol Obstet. 2013; 288: 125-130.
54. Nei M. Analysis of gene diversity in subdivided populations. Proc Natl Acad Sci U S A. 1973; 70: 3321-3323.
55. Excoffier L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances amongDNAhaplotypes: Application to human mitochondrialDNArestriction data. Genetics. 1992; 131: 479-491.
56. Linz B, Balloux F, Moodley Y, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007; 445: 915-918.
57. Stewart JF, Liu Y, Tauer CG, Nelson CD. Microsatellite versus AFLP analyses of pre-management introgression levels in loblolly pine (Pinus taeda L.) and shortleaf pine. (P. echinata Mill.). Tree Genetics, Genomes. 2010; 6: 853-862.
58. Legrand D, Vautrin D, Lachaise D, Cariou ML. Microsatellite variation suggests a recent fine-scale population structure of Drosophila sechellia, a species endemic of the Seychelles archipelago. Genetica. 2011; 139: 909-919.
59. TaylorSM, Antonia AL, ParobekCM, et al. Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR Congo. Sci Rep. 2013; 3: 1165.
60. Cox RM, Calsbeek R. Sexually antagonistic selection, sexual dimorphism, and the resolution of intralocus sexual conflict.AmNat. 2009; 173: 176-187.
61. Pennell TM, Morrow EH. Two sexes, one genome: The evolutionary dynamics of intralocus sexual conflict. Ecol Evol. 2013; 3: 1819-1834.
62. Ayub Q, Moutsianas L, Chen Y, et al. Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes. Am J Hum Genet. 2014; 94: 176-185.
63. Mills SC, Koskela E, MappesT. Intralocus sexual conflict for fitness: Sexually antagonistic alleles for testosterone. Proc Biol Sci. 2012; 279: 1889-1895.
64. Mainguy J, Côté SD, Festa-Bianchet M, Coltman DW. Father-offspring phenotypic correlations suggest intralocus sexual conflict for a fitness-linked trait in a wild sexually dimorphicmammal.Proc Biol Sci. 2009; 276: 4067-4075.
65. Delph LF, Andicoechea J, Steven JC, Herlihy CR, Scarpino SV, Bell DL. Environment-dependent intralocus sexual conflict in a dioecious plant. New Phytol. 2011; 192: 542-552.
66. Lewis Z, Wedell N, Hunt J. Evidence for strong intralocus sexual conflict in the Indian meal moth, Plodia interpunctella. Evolution. 2011; 65: 2085-2097.
67. Postma E, Spyrou N, Rollins LA, Brooks RC. Sex-dependent selection differentially shapes genetic variation on and off the guppy Y chromosome. Evolution. 2011; 65: 2145-2156.
68. Stearns SC, Govindaraju DR, Ewbank D, Byars SG. Constraints on the coevolution of contemporary human males and females. Proc Biol Sci. 2012; 279: 4836-4844.
69. Vasseur E, Quintana-Murci L. The impact of natural selection on health and disease: Uses of the population genetics approach in humans. Evol Appl. 2013; 6: 596-607.
70. Wang S, Lachance J, Tishkoff SA, Hey J, Xing J. Apparent Variation in Neanderthal Admixture among African Populations is Consistent with Gene Flow from non-African Populations. Genome Biol Evol. 2013; 5: 2075-2081.